Additionally, BIRC5 expression is also associated with histology subtypes, IDH1 mutation, 1p/19q chromosomal co-deletion, chemotherapy status, and MGMT promoter methylation status, well-established molecular characteristics of gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.